IDiyas

For the Inventor, By the Inventor

Freiburg, Germany

Rainer Machauer

USPTO Granted Patents = 20 

Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 124(Granted Patents)


Company Filing History:

goldMedal20 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2009-2025

where 'Filed Patents' based on already Granted Patents

20 patents (USPTO):
1. 12441733 - Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitors (2025-10-14),
2. 11702409 - Pyrazolyl derivatives useful as anti-cancer agents (2023-07-18),
3. 11613543 - Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors (2023-03-28),
4. 11541056 - 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives (2023-01-03),
5. 11203595 - Aza-indazole compounds for use in tendon and/or ligament injuries (2021-12-21),
6. 10766894 - Aza-indazole compounds for use in tendon and/or ligament injuries (2020-09-08),
7. 10683287 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2020-06-16),
8. 10301296 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2019-05-28),
9. 10112907 - Substituted indazoles for treating tendon and/or ligament injuries (2018-10-30),
10. 10035794 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2018-07-31),
11. 9550758 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2017-01-24),
12. 9284284 - Oxazine derivatives and their use in the treatment of disease (2016-03-15),
13. 9163011 - Oxazine derivatives and their use in the treatment of disease (2015-10-20),
14. 8865712 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2014-10-21),
15. 8637508 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2014-01-28),

Title: Rainer Machauer: Pioneering Innovations in Biomedical Research

Introduction:

Rainer Machauer, a visionary inventor based in Freiburg, Germany, is renowned for his relentless pursuit of innovation and his passion for pushing the boundaries of what is possible in the world of inventions. With a remarkable portfolio of 19 patents to his name, Machauer continues to inspire future generations of inventors and shape the technological advancements of tomorrow.

Latest Patents:

Machauer's latest patents include groundbreaking inventions such as "Pyrazolyl derivatives useful as anti-cancer agents," which introduces a novel compound formula for potential therapeutic uses in the fight against cancer. Additionally, his patent on "Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors" demonstrates his commitment to developing innovative solutions for the treatment of various diseases.

Career Highlights:

Currently affiliated with Novartis AG, a global leader in pharmaceuticals, Machauer's contributions have played a significant role in advancing biomedical research and drug discovery. His work at Novartis AG showcases his dedication to creating impactful inventions that have the potential to revolutionize healthcare.

Collaborations:

Throughout his career, Machauer has collaborated with esteemed professionals in the field, including his coworkers Marina Tintelnot-Blomley and Siem Jacob Veenstra. These collaborations have not only enriched his work but have also led to the development of groundbreaking inventions that address critical medical needs.

Conclusion:

In conclusion, Rainer Machauer's unwavering commitment to innovation and his groundbreaking inventions in the field of biomedical research have solidified his reputation as a true visionary. His work continues to pave the way for transformative advancements in healthcare and serves as an inspiration to inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…